loadpatents
Patent applications and USPTO patent grants for Zeng; Qingping.The latest application filed is for "ire1a inhibitor in combination with cancer therapeutic agent for cancer treatment".
Patent | Date |
---|---|
IRE-1.alpha. inhibitors Grant 11,337,956 - Zeng , et al. May 24, 2 | 2022-05-24 |
IRE1a INHIBITOR IN COMBINATION WITH CANCER THERAPEUTIC AGENT FOR CANCER TREATMENT App 20210260069 - ZENG; Qingping ;   et al. | 2021-08-26 |
Ire-1alpha Inhibitors App 20190314330 - ZENG; Qingping ;   et al. | 2019-10-17 |
IRE-1.alpha. inhibitors Grant 10,357,475 - Zeng , et al. July 23, 2 | 2019-07-23 |
Ire-1alpha Inhibitors App 20180228765 - Zeng; Qingping ;   et al. | 2018-08-16 |
IRE-1.alpha. inhibitors Grant 9,981,901 - Patterson , et al. May 29, 2 | 2018-05-29 |
IRE-1alpha INHIBITORS App 20180072745 - Zeng; Qingping ;   et al. | 2018-03-15 |
IRE-1.alpha. inhibitors Grant 9,867,803 - Zeng , et al. January 16, 2 | 2018-01-16 |
IRE-1alpha inhibitors Grant 9,856,266 - Zeng , et al. January 2, 2 | 2018-01-02 |
Multiple kinase pathway inhibitors Grant 9,714,247 - Zeng , et al. July 25, 2 | 2017-07-25 |
IRE-1.alpha. inhibitors Grant 9,693,992 - Zeng , et al. July 4, 2 | 2017-07-04 |
IRE-1alpha INHIBITORS App 20170166576 - Zeng; Qingping ;   et al. | 2017-06-15 |
IRE-1alpha INHIBITORS App 20170152206 - Patterson; John B. ;   et al. | 2017-06-01 |
Multiple Kinase Pathway Inhibitors App 20170107215 - Zeng; Qingping ;   et al. | 2017-04-20 |
IRE-1.alpha. inhibitors Grant 9,493,435 - Zeng , et al. November 15, 2 | 2016-11-15 |
Multiple kinase pathway inhibitors Grant 9,493,454 - Zeng , et al. November 15, 2 | 2016-11-15 |
IRE-1.alpha. inhibitors Grant 9,241,942 - Patterson , et al. January 26, 2 | 2016-01-26 |
Multiple Kinase Pathway Inhibitors App 20150266870 - Zeng; Qingping ;   et al. | 2015-09-24 |
IRE-1.alpha. inhibitors Grant 9,040,714 - Zeng , et al. May 26, 2 | 2015-05-26 |
IRE-1alpha INHIBITORS App 20150141424 - ZENG; Qingping ;   et al. | 2015-05-21 |
IRE-1alpha INHIBITORS App 20140080832 - PATTERSON; John Bruce ;   et al. | 2014-03-20 |
IRE-1.alpha. inhibitors Grant 8,614,253 - Patterson , et al. December 24, 2 | 2013-12-24 |
IRE-1alpha INHIBITORS App 20130116247 - Zeng; Qingping ;   et al. | 2013-05-09 |
IRE-1alpha INHIBITORS App 20120270877 - Zeng; Qingping ;   et al. | 2012-10-25 |
Thiazole compounds and methods of use Grant 8,084,479 - Zeng , et al. December 27, 2 | 2011-12-27 |
Fluoroisoquinoline Substituted Thiazole Compounds And Methods Of Use App 20110263647 - Zeng; Qingping ;   et al. | 2011-10-27 |
Thiadiazole modulators of PKB Grant 7,919,504 - Zeng , et al. April 5, 2 | 2011-04-05 |
Thiadiazole compounds and methods of use Grant 7,919,514 - Monenschein , et al. April 5, 2 | 2011-04-05 |
IRE-1alpha INHIBITORS App 20110065162 - PATTERSON; JOHN B. ;   et al. | 2011-03-17 |
Heterocyclic modulators of PKB Grant 7,897,619 - Zeng , et al. March 1, 2 | 2011-03-01 |
IRE-1.alpha. inhibitors Grant 7,858,666 - Patterson , et al. December 28, 2 | 2010-12-28 |
Thiadiazole compounds and methods of use Grant 7,700,636 - Monenschein , et al. April 20, 2 | 2010-04-20 |
Thiadiazole modulators of PKB App 20090298836 - Zeng; Qingping ;   et al. | 2009-12-03 |
Heterocyclic modulators of PKB App 20090275592 - ZENG; Qingping ;   et al. | 2009-11-05 |
Thiazole compounds and methods of use App 20090270445 - Zeng; Qingping ;   et al. | 2009-10-29 |
IRE-1alpha INHIBITORS App 20090186893 - PATTERSON; John B. ;   et al. | 2009-07-23 |
Thiazole compounds and methods of use Grant 7,514,566 - Zeng , et al. April 7, 2 | 2009-04-07 |
Thiadiazole compounds and methods of use App 20080269243 - Monenschein; Holger ;   et al. | 2008-10-30 |
Thiadiazole compounds and methods of use App 20080255145 - Monenschein; Holger ;   et al. | 2008-10-16 |
Thiadiazole compounds and methods of use Grant 7,354,944 - Zeng , et al. April 8, 2 | 2008-04-08 |
Thiazole compounds and methods of use App 20070173506 - Zeng; Qingping ;   et al. | 2007-07-26 |
Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade Grant 7,119,094 - South , et al. October 10, 2 | 2006-10-10 |
Thiadiazole compounds and methods of use App 20060154961 - Zeng; Qingping ;   et al. | 2006-07-13 |
Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade App 20050165062 - South, Michael S. ;   et al. | 2005-07-28 |
Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade Grant 6,908,919 - South , et al. June 21, 2 | 2005-06-21 |
Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade Grant 6,867,217 - South , et al. March 15, 2 | 2005-03-15 |
Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade App 20050043313 - South, Michael S. ;   et al. | 2005-02-24 |
6-Membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade App 20040106626 - South, Michael S. ;   et al. | 2004-06-03 |
Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade App 20040102448 - South, Michael S. ;   et al. | 2004-05-27 |
Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade App 20040082585 - South, Michael S. ;   et al. | 2004-04-29 |
Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade App 20040006230 - South, Michael S. ;   et al. | 2004-01-08 |
Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade Grant 6,664,255 - South , et al. December 16, 2 | 2003-12-16 |
Ion triggered alkylation of biological targets by silyloxy aromatic agents Grant 5,831,073 - Rokita , et al. November 3, 1 | 1998-11-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.